标题
Antiobesity Pharmacotherapy in Adults with Chronic Kidney Disease
作者
关键词
-
出版物
KIDNEY INTERNATIONAL
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-11-04
DOI
10.1016/j.kint.2023.10.014
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared to placebo
- (2023) Katherine R. Tuttle et al. KIDNEY INTERNATIONAL
- The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
- (2023) Peter Rossing et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of Tirzepatide Versus Insulin Glargine on Cystatin C–Based Kidney Function: A SURPASS-4 Post Hoc Analysis
- (2023) Hiddo J.L. Heerspink et al. DIABETES CARE
- Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials
- (2023) Hiddo J.L. Heerspink et al. DIABETES CARE
- Medicare Part D Coverage of Antiobesity Medications — Challenges and Uncertainty Ahead
- (2023) Khrysta Baig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Benefits of bariatric surgery on microvascular outcomes in adult patients with type 2 diabetes: a systematic review and meta-analysis
- (2023) Javier Obeso-Fernández et al. Surgery for Obesity and Related Diseases
- Prevalence of Chronic Kidney Disease in China
- (2023) Limin Wang et al. JAMA Internal Medicine
- Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
- (2023) Vanita R Aroda et al. LANCET
- Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
- (2023) Julio Rosenstock et al. LANCET
- Unanswered questions about the causes of obesity
- (2023) John R. Speakman et al. SCIENCE
- Sleeve gastrectomy in subjects with severe obesity and baseline chronic kidney disease improves kidney function independently of weight loss. A propensity score matched analysis
- (2022) David Romero Funes et al. Surgery for Obesity and Related Diseases
- Incidence and Characteristics of Remission of Type 2 Diabetes in England: A Cohort Study Using the National Diabetes Audit
- (2022) Naomi Holman et al. DIABETES CARE
- Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study
- (2022) Violeta Raverdy et al. Lancet Diabetes & Endocrinology
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obesity-Related Chronic Kidney Disease: Principal Mechanisms and New Approaches in Nutritional Management
- (2022) Alessandra Stasi et al. Frontiers in Nutrition
- Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society
- (2022) Allon N. Friedman et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
- (2022) Tamer Coskun et al. Cell Metabolism
- Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
- (2022) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- Prevalence of Obesity and CKD Among Adults in the United States, 2017-2020
- (2022) Allon N. Friedman et al. Kidney Medicine
- Management of Obesity in Adults with CKD
- (2021) Allon N. Friedman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential kidney protection with liraglutide and semaglutide – exploratory mediation analysis
- (2021) Johannes F. E. Mann et al. DIABETES OBESITY & METABOLISM
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
- (2021) Lone B Enebo et al. LANCET
- Phentermine-Induced Acute Kidney Injury Secondary to Uncontrolled Hypertension in a Patient with Weight Regain Post-bariatric Surgery
- (2021) Marvin Wei Jie Chua et al. OBESITY SURGERY
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural Brain Changes Associated with Overweight and Obesity
- (2021) Erick Gómez-Apo et al. Journal of Obesity
- Rare genetic causes of obesity: Diagnosis and management in clinical care
- (2021) Béatrice Dubern et al. ANNALES D ENDOCRINOLOGIE
- Anti-obesity drug discovery: advances and challenges
- (2021) Timo D. Müller et al. NATURE REVIEWS DRUG DISCOVERY
- SGLT inhibitors on weight and body mass: A meta‐analysis of 116 randomized‐controlled trials
- (2021) Alex Jia Yang Cheong et al. Obesity
- Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–2020
- (2021) Abdulrahman Alsuhibani et al. International Journal of Clinical Pharmacy
- Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System
- (2021) Soraya Puglisi et al. Frontiers in Endocrinology
- Safety of Liraglutide in Type 2 Diabetes and Chronic Kidney Disease
- (2020) Johannes F.E. Mann et al. Clinical Journal of the American Society of Nephrology
- Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial
- (2020) Rory J. McCrimmon et al. DIABETOLOGIA
- GLP-1 Alleviates Diabetic Kidney Disease Through Activation of Autophagy by Regulating AMPK/mTOR Pathway
- (2020) Shuangli Yang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Endogenous Activation of Glucagon-Like Peptide-1 Receptor Contributes to Blood Pressure Control
- (2020) Flavia L. Martins et al. HYPERTENSION
- Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
- (2020) Karine Clément et al. Lancet Diabetes & Endocrinology
- The relationship between kidney function and body mass index before and after bariatric surgery in patients with chronic kidney disease
- (2020) Heidi Fischer et al. Surgery for Obesity and Related Diseases
- Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium
- (2019) Alex R Chang et al. BMJ-British Medical Journal
- Metabolic surgery improves renal injury independent of weight loss: a meta-analysis
- (2019) Katharina M. Scheurlen et al. Surgery for Obesity and Related Diseases
- A comprehensive diagnostic approach to detect underlying causes of obesity in adults
- (2019) Eline S. van der Valk et al. Obesity Reviews
- Higher body mass index is associated with incident diabetes and chronic kidney disease independent of genetic confounding
- (2019) Hong Xu et al. KIDNEY INTERNATIONAL
- Protective effects of liraglutide on glomerular podocytes in obese mice by inhibiting the inflammatory factor TNF-α-mediated NF-κB and MAPK pathway
- (2019) Yongjian Ye et al. Obesity Research & Clinical Practice
- The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes
- (2019) Allon N. Friedman et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Body weight management and safety with efpeglenatide in adults without diabetes: a phase II randomized study
- (2019) Richard E. Pratley et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide-1 receptor pathway inhibits extracellular matrix production by mesangial cells through store-operated Ca2+ channel
- (2019) Linjing Huang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007–2015: A registry-based cohort study
- (2019) Anders Jans et al. PLOS MEDICINE
- Podocyte hypertrophic stress and detachment precedes hyperglycemia or albuminuria in a rat model of obesity and type2 diabetes-associated nephropathy
- (2019) Akihiro Minakawa et al. Scientific Reports
- Impact of Obesity on Modality Longevity, Residual Kidney Function, Peritonitis, and Survival Among Incident Peritoneal Dialysis Patients
- (2018) Yoshitsugu Obi et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
- (2018) Charlotte Granhall et al. CLINICAL PHARMACOKINETICS
- Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
- (2018) Michael EJ Lean et al. LANCET
- Maintenance of Lost Weight and Long-Term Management of Obesity
- (2018) Kevin D. Hall et al. MEDICAL CLINICS OF NORTH AMERICA
- Obesity and chronic kidney disease: A population-based study among South Koreans
- (2018) Lorraine S. Evangelista et al. PLoS One
- GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis
- (2018) Chengshi Wang et al. PLoS One
- Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- (2018) Johannes F. E. Mann et al. CIRCULATION
- FSGS as an Adaptive Response to Growth-Induced Podocyte Stress
- (2017) Ryuzoh Nishizono et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
- (2017) Marcel H. A. Muskiet et al. Nature Reviews Nephrology
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Complementary Hypotheses on Contributors to the Obesity Epidemic
- (2017) Rachel A.H. Davis et al. Obesity
- Effect of Roux-en-Y gastric bypass and diet-induced weight loss on diabetic kidney disease in the Zucker diabetic fatty rat
- (2017) Karl J. Neff et al. Surgery for Obesity and Related Diseases
- Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?
- (2016) Karly C. Sourris et al. CURRENT DRUG TARGETS
- Weight loss at a high cost: Orlistat-induced late-onset severe kidney disease
- (2016) B. Buysschaert et al. DIABETES & METABOLISM
- The effect of liraglutide on renal function: A randomized clinical trial
- (2016) Bernt J. von Scholten et al. DIABETES OBESITY & METABOLISM
- Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study
- (2016) Amalia Gastaldelli et al. HEPATOLOGY
- Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
- (2016) Vivette D. D'Agati et al. Nature Reviews Nephrology
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Impact of Obesity on Allograft Failure After Kidney Transplantation
- (2016) Abhijit S. Naik et al. TRANSPLANTATION
- Position of the Academy of Nutrition and Dietetics: Obesity, Reproduction, and Pregnancy Outcomes
- (2016) Jamie Stang et al. Journal of the Academy of Nutrition and Dietetics
- Body mass index and outcome in renal transplant recipients: a systematic review and meta-analysis
- (2015) Jeffrey A Lafranca et al. BMC Medicine
- Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
- (2015) Melanie J. Davies et al. DIABETES CARE
- Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blinded, Parallel Group, Randomized Trial
- (2015) Thomas Idorn et al. DIABETES CARE
- Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis
- (2015) Feng Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- When Arteriovenous Fistulas Are Too Deep: Options in Obese Individuals
- (2015) C. Miles Maliska et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leptin Mediates the Increase in Blood Pressure Associated with Obesity
- (2014) Stephanie E. Simonds et al. CELL
- Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008–12 National Health Examination Survey
- (2014) Luca De Nicola et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of Hemodialysis on Plasma Glucose Profile and Plasma Level of Liraglutide in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease: A Pilot Study
- (2014) Takeshi Osonoi et al. PLoS One
- Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease
- (2014) Aiko P J de Vries et al. Lancet Diabetes & Endocrinology
- Role of advanced glycation end products in cellular signaling
- (2014) Christiane Ott et al. Redox Biology
- Predicting the Glomerular Filtration Rate in Bariatric Surgery Patients
- (2013) Allon N. Friedman et al. AMERICAN JOURNAL OF NEPHROLOGY
- Short-Term Changes after a Weight Reduction Intervention in Advanced Diabetic Nephropathy
- (2013) A. N. Friedman et al. Clinical Journal of the American Society of Nephrology
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- The Glucagon-Like Peptide-1 Receptor Agonist, Liraglutide, Attenuates the Progression of Overt Diabetic Nephropathy in Type 2 Diabetic Patients
- (2013) Shigeki Imamura et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Mechanisms underlying current and future anti-obesity drugs
- (2013) Roger A.H. Adan TRENDS IN NEUROSCIENCES
- Body Mass Index in 1.2 Million Adolescents and Risk for End-Stage Renal Disease
- (2012) Asaf Vivante et al. ARCHIVES OF INTERNAL MEDICINE
- Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes
- (2012) Edward W. Gregg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Causes of obesity
- (2012) Suzanne M. Wright et al. Abdominal Radiology
- Orlistat and Acute Kidney Injury: An Analysis of 953 Patients
- (2011) Matthew A. Weir ARCHIVES OF INTERNAL MEDICINE
- Short-Term Exenatide Treatment Leads to Significant Weight Loss in a Subset of Obese Women Without Diabetes
- (2011) J. Dushay et al. DIABETES CARE
- Fatty Kidney, Hypertension, and Chronic Kidney Disease
- (2011) Meredith C. Foster et al. HYPERTENSION
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Rhabdomyolysis associated with phentermine
- (2010) K. E. Steidl et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes
- (2010) J. Rosenstock et al. DIABETES CARE
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- Nonrandomized Trial of Weight Loss With Orlistat, Nutrition Education, Diet, and Exercise in Obese Patients With CKD: 2-Year Follow-up
- (2009) Helen L. MacLaughlin et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide
- (2009) Lisbeth V. Jacobsen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Challenges of Treating a 466-Kilogram Man With Acute Kidney Injury
- (2008) Allon N. Friedman et al. AMERICAN JOURNAL OF KIDNEY DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation